R&D
A certificate of analysis should be evidence, not a sales do...
Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.
News
Blackstone buys into Pfizer's GLP-1 drug development
Blackstone Life Sciences will provide up to $1.5bn in funding to Pfizer for the development of its once-monthly GLP-1 agonist berobenatide.
R&D
From phase 1 to phase 3: Scaling radiopharmaceutical trials
Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.
R&D
Gravity is an experimental variable pharma has rarely been a...
Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.
News
UK's Levicept builds case for osteoarthritis therapy at ACR
New data on Levicept's LEVI-04 in patients with osteoarthritis support its potential to become the first new systemic treatment in over two decades.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
